| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |